|
|
Blood, 1 April 2006, Vol. 107, No. 7, pp. 2943-2951.
Prepublished online as a Blood First Edition Paper on December 20, 2005; DOI 10.1182/blood-2005-10-3992.
Previous Article | Next Article 
Submitted October 6, 2005
Accepted November 14, 2005
Red blood cells express a functional endothelial nitric oxide synthase
Petra Kleinbongard, Rainer Schulz, Tienush Rassaf, Thomas Lauer, Andre Dejam, Thomas Jax, Intan Kumara, Putrika Gharini, Svetlana Kabanova, Burcin Oezueyaman, Hans-Georg Schnurch, Axel Godecke, Artur-Aron Weber, Mirko Robenek, Horst Robenek, Wilhelm Bloch, Peter Rosen, and Malte Kelm*
Department of Medicine, Medical Clinic I, University Hospital RTWH Aachen, Aachen, Germany
Institute of Pathophysiology, Medical School, University of Essen, Essen, Germany
Department of Medicine, Division of Cardiology, Pulmonary Diseases and Angiology, Heinrich-Heine-University, Duesseldorf, Germany
Department of Gynaecology and Obstetrics, Lukas Hospital, Neuss, Germany
Department of Cardiovascular Physiology, Heinrich-Heine-University, Duesseldorf, Germany
Department of Pharmacology, Heinrich-Heine-University, Duesseldorf, Germany
Department of Cell Biology and Ultrastructure Research, Leibniz-Institute of Artheriosclerosis Research, Munster, Germany
Department of Molecular and Cellular Sport Medicine, Sport University Cologne, Cologne, Germany
Department of Clinical Biochemistry, German Diabetes Research Institute, Heinrich-Heine-University, Duesseldorf, Germany
* Corresponding author; email: kelm{at}uni-duesseldorf.de.
The synthesis of nitric oxide (NO) in the circulation has been attributed exclusively to the vascular endothelium. Red blood cells (RBC) have been demonstrated to carry a non-functional NO synthase (NOS) and, due to their huge hemoglobin content, have been assumed to metabolize large quantities of NO. More recently, however, RBC have been identified to reversibly bind, transport, and release NO within the cardiovascular system. We now provide evidence that RBC from humans express an active and functional endothelial type NOS (eNOS), which is localized in the plasma membrane and the cytoplasm of RBC. This NOS is regulated by its substrate L-arginine, by calcium and by phosphorylation via PI3 kinase. RBC-NOS activity regulates deformability of RBC-membrane, and inhibits activation of platelets. The NOS dependent conversion of L-arginine in RBC is comparable to that of cultured human endothelial cells. RBC in eNOS-/- mice in contrast to wild-type mice lack NOS protein and activity strengthening the evidence of an eNOS in RBC. These data show an eNOS like protein and activity in RBC serving regulatory functions in RBC and platelets, which may stimulate new approaches in the treatment of NO deficiency states inherent to several vascular and hematologic diseases.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Does eNOS stand for erythrocytic NO synthase?
- Mark T. Gladwin
Blood 2006 107: 2595-2596.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
E. M. Pasini, M. Kirkegaard, D. Salerno, P. Mortensen, M. Mann, and A. W. Thomas
Deep Coverage Mouse Red Blood Cell Proteome: A First Comparison with the Human Red Blood Cell
Mol. Cell. Proteomics,
July 1, 2008;
7(7):
1317 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Foller, S. Feil, K. Ghoreschi, S. Koka, A. Gerling, M. Thunemann, F. Hofmann, B. Schuler, J. Vogel, B. Pichler, et al.
Anemia and splenomegaly in cGKI-deficient mice
PNAS,
May 6, 2008;
105(18):
6771 - 6776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. P. Cokic, S. A. Andric, S. S. Stojilkovic, C. T. Noguchi, and A. N. Schechter
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
Blood,
February 1, 2008;
111(3):
1117 - 1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. M. Fischer, R. Schindler, K. Brixius, U. Mehlhorn, and W. Bloch
Extracorporeal Circulation Activates Endothelial Nitric Oxide Synthase in Erythrocytes
Ann. Thorac. Surg.,
December 1, 2007;
84(6):
2000 - 2003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Erzurum, S. Ghosh, A. J. Janocha, W. Xu, S. Bauer, N. S. Bryan, J. Tejero, C. Hemann, R. Hille, D. J. Stuehr, et al.
Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans
PNAS,
November 6, 2007;
104(45):
17593 - 17598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Reynolds, G. S. Ahearn, M. Angelo, J. Zhang, F. Cobb, and J. S. Stamler
S-nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked blood
PNAS,
October 23, 2007;
104(43):
17058 - 17062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bennett-Guerrero, T. H. Veldman, A. Doctor, M. J. Telen, T. L. Ortel, T. S. Reid, M. A. Mulherin, H. Zhu, R. D. Buck, R. M. Califf, et al.
Evolution of adverse changes in stored RBCs
PNAS,
October 23, 2007;
104(43):
17063 - 17068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Dudzinski and T. Michel
Life history of eNOS: Partners and pathways
Cardiovasc Res,
July 15, 2007;
75(2):
247 - 260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Minetti, L. Agati, and W. Malorni
The microenvironment can shift erythrocytes from a friendly to a harmful behavior: Pathogenetic implications for vascular diseases
Cardiovasc Res,
July 1, 2007;
75(1):
21 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Rathod, A. J. Webb, M. J. Lovell, F. Lecomte, and A. Ahluwalia
Nitrite Is Reduced to Nitric Oxide by Xanthine Oxidoreductase and Nitric Oxide Synthase in the Erythrocyte Membrane in Hypoxemia.
Blood (ASH Annual Meeting Abstracts),
November 16, 2006;
108(11):
1560 - 1560.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kelm
Significance of Vascular Nitric Oxide Synthase Pathways in Coronary Artery Disease: A Multiple-Level Biomarker Strategy
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1175 - 1176.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, N. S. Bryan, P. H. MacArthur, J. Rodriguez, M. T. Gladwin, and M. Feelisch
Measurement of Nitric Oxide Levels in the Red Cell: VALIDATION OF TRI-IODIDE-BASED CHEMILUMINESCENCE WITH ACID-SULFANILAMIDE PRETREATMENT
J. Biol. Chem.,
September 15, 2006;
281(37):
26994 - 27002.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|